ArticleBMC cancer2018

Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort.

Yvonne Huber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.